Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.88 -0.01 (-0.15%)
At close: Nov 11, 2026 · 4:00 PM EST

Cartesian Therapeutics (RNAC) EV to FCF (2020 - 2021)

Updated

Cartesian Therapeutics' EV to FCF was 365.36 in Q2 2021, down 18.8% from the prior quarter.

Analysis

Cartesian Therapeutics (RNAC) EV to FCF (2020 - 2021) Analysis & Trends

On a trailing twelve-month basis, Cartesian Therapeutics' EV to FCF was 354.29 through Jun 30, 2021; for FY2020, it came in at 284.30.

  • Quarterly EV to FCF has moved between 273.92 (Q3 2020) and 450.16 (Q1 2021) over five years.
  • Per Business Quant data, RNAC's EV to FCF in the three quarters before Q2 2021 was 450.16 (Q1 2021), 284.30 (Q4 2020) and 273.92 (Q3 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cartesian Therapeutics 210.06 Mn -304.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 365.36
Mar 31, 2021 450.16
Dec 31, 2020 284.30
Sep 30, 2020 273.92
API Access

Cartesian Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=RNAC&period=max&api_key=YOUR_API_KEY